NVCR Q4 2023 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q4 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$134M+4.2% YoY

Gross Profit

$101M75.7% margin

Operating Income

-$52M-38.7% margin

Net Income

-$47M-35.2% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

+5.1%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$21M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$784M

Stockholders' Equity

$362M

Cash & Equivalents

$241M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$134M	$128M	+4.2%
Gross Profit	$101M	$100M	+1.7%
Operating Income	-$52M	-$43M	-20.3%
Net Income	-$47M	-$37M	-26.2%

Geographic Segments

UNITED STATES

$91M77%

GERMANY

$15M12%

JAPAN

$8M6%

CHINA

$4M4%